Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 17 (Search time: 0.001 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
1-Apr-2005Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trialsDrevs, J; Zirrgiebel, U; Schmidt-Gersbach, CIM; Mross, K; Medinger, M; Lee, L; Pinheiro, J; Wood, J; Thomas, AL; Unger, C; Henry, A; Steward, WP; Laurent, D; Lebwohl, D; Dugan, M; Marme, DJournal Article
1-Jan-2001Involving patients in treatment decisions: Can we learn from clinical trials?Sharma, RA; Symonds, RP; O'Byrne, KJ; Cheater, F; Abrams, KR; Steward, WPJournal Article
1-May-1999Marimastat (BB2516): Current status of developmentSteward, WPJournal Article
1-Feb-2000Angiogenesis and non-small cell lung cancerCox, G; Jones, JL; Walker, RA; Steward, WP; O'Byrne, KJJournal Article
1-Jan-2000The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant diseaseO'Byrne, KJ; Dalgleish, AG; Browning, MJ; Steward, WP; Harris, ALJournal Article
1-Dec-2000Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating studyThomas, AL; Cox, G; Sharma, RA; Steward, WP; Shields, F; Jeyapalan, K; Muller, S; O'Byrne, KJJournal Article
1-Sep-1999A bio-availability study of OGT 719 following oral and intravenous administrationEatock, MM; Sharma, RA; Fyfe, D; Brown, G; Moyses, C; Twelves, CJ; Steward, WP; Carmichael, JJournal Article
1-Oct-2001A phase II study of Caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancerThomas, AL; O'Byrne, K; Furber, L; Jeffery, K; Steward, WPJournal Article
1-Sep-2001Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cellsSharma, RA; Gescher, A; Plastaras, JP; Leuratti, C; Singh, R; Gallacher-Horley, B; Offord, E; Marnett, LJ; Steward, WP; Plummer, SMJournal Article
1-Jun-2006Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastasesLee, L; Sharma, S; Morgan, B; Allegrini, P; Schnell, C; Brueggen, J; Cozens, R; Horsfield, M; Guenther, C; Steward, WP; Drevs, J; Lebwohl, D; Wood, J; McSheehy, PMJJournal Article